October 23, 2022
2 min watch
Save
VIDEO: Aerie gives update on dry eye, glaucoma clinical trials
Issue: November 25, 2022
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Michelle Senchyna, PhD, of Aerie Pharmaceuticals, provides an update on the company’s ongoing projects.
Senchyna discusses clinical studies investigating AR-15512 for the treatment of dry eye disease and Rocklatan (netarsudil 0.02% and latanoprost 0.005% ophthalmic solution) for the treatment of glaucoma.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Senchyna reports being the vice president of clinical development and medical affairs at Aerie.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.